Recent COGT News
- Cogent Biosciences Announces Participation in the Leerink Healthcare Conference • GlobeNewswire Inc. • 03/07/2025 01:00:00 PM
- Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients • GlobeNewswire Inc. • 02/27/2025 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/25/2025 09:02:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 01:20:03 PM
- Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 02/25/2025 01:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2025 09:35:41 PM
- Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting • GlobeNewswire Inc. • 02/10/2025 02:15:00 PM
- Cogent Biosciences to Participate in the Guggenheim Biotech Conference • GlobeNewswire Inc. • 01/30/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2025 10:03:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2025 10:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2025 09:58:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2025 09:56:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2025 09:55:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2025 12:00:04 PM
- Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 09:01:29 PM
- Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients • GlobeNewswire Inc. • 12/09/2024 12:00:00 PM
- Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) • GlobeNewswire Inc. • 12/08/2024 05:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:05:10 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 05:24:46 PM
- Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting • GlobeNewswire Inc. • 11/05/2024 02:00:00 PM
- Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics • GlobeNewswire Inc. • 10/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:15:59 PM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM
Nightfood Holdings, Inc. (NGTF) Signs Letter of Intent to Acquire Skytech Automated Solutions Inc. to Expand AI-Powered Robotics Portfolio • NGTF • Mar 5, 2025 8:44 AM
North Bay Resources Announces Refinery Shipment of Gold Concentrate from Bishop Gold Mill • NBRI • Mar 4, 2025 9:00 AM
UAV Corp. Secures LOI for Multi-Unit Purchase of DART 600 Airship Systems • UMAV • Mar 4, 2025 8:30 AM
UCASU Expected to Report $0.02/share Net Profit for 2024 • UCASU • Mar 3, 2025 1:55 PM